Effects of Antiviral Therapies on Epstein-Barr Virus Replication
Latest Information Update: 26 Nov 2024
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications Epstein-Barr virus infections
- Focus Therapeutic Use
Most Recent Events
- 22 Nov 2024 Planned End Date changed from 31 Dec 2024 to 31 Dec 2025.
- 22 Nov 2024 Planned primary completion date changed from 4 Jun 2024 to 4 Jun 2025.
- 26 Jul 2023 New trial record